• Phare
  • Validé par KD/KO

Anticorps Recombinant de lapin anti-PAK7

PAK7 Recombinant Antibody for WB, FC (Intra), Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

WB, FC (Intra), Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

230201A10

N° de cat : 82935-1-PBS

Synonymes

PAK4/6/7, 230201A10, EC:2.7.11.1, KIAA1264, p21-activated kinase 5



Informations sur le produit

82935-1-PBS cible PAK7 dans les applications de WB, FC (Intra), Indirect ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène PAK7 Protéine recombinante Ag29190
Nom complet p21 protein (Cdc42/Rac)-activated kinase 7
Masse moléculaire calculée 719 aa, 81 kDa
Poids moléculaire observé70 kDa
Numéro d’acquisition GenBankBC024179
Symbole du gène PAK7
Identification du gène (NCBI) 57144
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

PAK7, also known as PAK5, is a newly found but scarcely researched type II PAKs (PAK4, 5, 6). PAK7 was originally found in the brain, which promotes filopodia formation in nerve cells. Recently, studies have found that the expression level of PAK7 significantly increased in colorectal cancer, ovarian cancer, gastric cancer, neuroglioma, hepatocellular carcinoma, pancreatic cancer, osteosarcoma, and breast cancer. PAK7 plays an important role in tumorigenesis, invasion, and metastasis, mainly related to its mechanism of regulating cytoskeleton, inhibiting apoptosis, and promoting proliferation. The calculated molecular weight of PAK7 is 80 kDa (PMID: 29805709, PMID: 34165002).

{{ptg:RelatedPrimaryAntibodies}}